Concepedia

Publication | Open Access

Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2

186

Citations

56

References

2005

Year

Abstract

These preclinical findings support the development of SAHA in combination with docetaxel and/or trastuzumab against Her-2-amplified breast cancer.

References

YearCitations

Page 1